QURE: This seems to be accompanied by BMY optioning 3 new targets for the CV collaboration. They were already working on S100A1 together, and they have repeatedly dubbed this protein a "master regulator" for heart function. I guess this means the 3 new targets are not as important because they were already working on the master regulator. Language is important.